Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Arch Pediatr ; 29(8): 581-587, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36109288

ABSTRACT

INTRODUCTION: Pediatric chronic pain can lead to serious consequences in terms of daily functioning and global quality of life. Mindfulness-based intervention (MBI) approaches that emphasize accepting rather than controlling pain have gained increasing attention in adults with chronic pain. The effectiveness of MBIs for chronic pain in the pediatric population remains unknown. The aim of the Peacefull program was to study the feasibility in France of a mindfulness program for adolescents with chronic pain, based on a program especially developed in Canada and Belgium. METHOD: An MBI for adolescents consisting of eight 90-min sessions was provided. It focused on building skills and incorporated mindfulness meditation, exercises, and activities especially adapted to teenagers with chronic pain. RESULTS: A total of 27 adolescents aged 12-17 years who were diagnosed with a chronic pain condition were enrolled in five cohorts from April 2018 to June 2021. The completion rate of the Peacefull program was 88.89 with no dropouts and good completion of outcome measures. Secondary outcomes were assessed before the program, at the end, and 3 months later. A trend toward an improvement was observed on the mean average score for the Visual Analog Scale (VAS), but it was not statistically significant. Scores increased significantly over time on the Functional Disability Inventory (FDI), and pain catastrophizing also improved. CONCLUSIONS: Although the findings regarding the effectiveness of Peacefull programs were inconsistent and insufficient, they can be indicative of the benefits of mindfulness as an adjuvant treatment for adolescents with chronic pain.


Subject(s)
Chronic Pain , Mindfulness , Adult , Adolescent , Child , Humans , Chronic Pain/therapy , Feasibility Studies , Quality of Life , Treatment Outcome , Chronic Disease
2.
Arch Pediatr ; 28(7): 548-552, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34400053

ABSTRACT

INTRODUCTION: Pediatric palliative care (PPC) teams address unmet needs and improve the quality of life of patients with life-limiting conditions across pediatric subspecialties. However, little is known about the timing, reasons, and nature of PPC team interventions in advanced heart diseases (AHD). OBJECTIVES: Here we describe how, when, and why PPC teams interact with referred teams of children suffering from AHD. METHODS: We conducted a retrospective nationwide survey among PPC teams in France. All patients referred to participating PPC teams for a cardiologic disease in 2019 were studied. RESULTS: Among six PPC teams, 18 patients with AHD had a PPC consultation in 2019. Six of these patients had cardiomyopathy and 12 had congenital heart disease (CHD). The median age at referral was 0.9 months for CHD and 72 months for cardiomyopathy. An antenatal diagnosis had been made for six families with CHD, and two of them were referred to PPC before birth allowing for a prenatal palliative care plan. The main reason for referral was ethical considerations (50%) followed by organization for home-based palliative care (28%). PPC teams participated in ethical discussions when asked to but also provided family support (12/18), home-based PPC (9/18), coordination of care (5/18), support of the referred team (4/18), and symptoms management (3/18) CONCLUSION: The main reason for referral to PPC was ethical considerations, but PPC interventions followed a holistic model of care. Prospective outcomes measurement and partnerships should be further developed.


Subject(s)
Heart Diseases/therapy , Palliative Care/statistics & numerical data , Adolescent , Child , Child, Preschool , Female , France/epidemiology , Heart Diseases/epidemiology , Humans , Infant , Male , Palliative Care/methods , Pediatrics/methods , Pediatrics/statistics & numerical data , Prospective Studies , Retrospective Studies , Surveys and Questionnaires
3.
Encephale ; 46(5): 356-363, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32921494

ABSTRACT

Losing a loved one is among the most common and stressful traumatic events that a child or and adolescent can experience and can be associated with mental health and somatic disorders, as well as a range of life issues and potentially negative outcomes that may impact longitudinal development. Complicated grief, a disorder that has been studied primarily among adults, has received increasing recognition among children and adolescents in recent years. The demonstration of the distinctive character of grief reactions in relation to major depressive disorder and posttraumatic stress disorder has resulted in the inclusion of "persistent complex bereavement disorder" in an annex section of DSM-5 and of "prolonged grief disorder" in ICD-11. The grieving process in children and adolescents is not linear and is often characterised by periods of regression. Developmental phases should be taken into account to understand and clinically describe grief reactions occurring during childhood and adolescence. There are currently numerous interventions for bereaved children and adolescents, but little evidence to support them. More research focusing on the understanding of the underlying mechanisms and the risk factors for complicated grief among children and adolescents, as well as the implementation of evidence-based interventions, is definitely warranted.


Subject(s)
Bereavement , Depressive Disorder, Major , Adolescent , Adult , Child , Depressive Disorder, Major/epidemiology , Diagnostic and Statistical Manual of Mental Disorders , Grief , Humans , International Classification of Diseases
4.
Ann Dermatol Venereol ; 143(12): 836-840, 2016 Dec.
Article in French | MEDLINE | ID: mdl-27496274

ABSTRACT

BACKGROUND: Pansclerotic morphea is a poorly described but extremely debilitating variant of localized scleroderma. We report a case with a rapidly fatal outcome in an 11-year-old girl. PATIENTS AND METHODS: An 11-year-old girl with a 2-year history of morphea presented at our institution in April 2012. The sclerosis had started on her trunk and progressed rapidly to involve her entire skin. Initial treatment with corticosteroids was ineffective and she presented extremely painful ulcerations of the lower limbs. The outcome was rapidly fatal, in early 2014, due to cachexia and sepsis after two amputations and several failed treatments including methotrexate. DISCUSSION: Pansclerotic morphea is characterized by rapidly progressing sclerosis involving the entire skin, trophic cutaneous ulcers, painful contraction and limited joint mobility. The prognosis is poor since the disease has an incapacitating and potentially fatal outcome. No reliably effective treatment has yet been established. CONCLUSION: Our case highlights the clinical characteristics of this uncommon form of localized scleroderma, the extremely severe prognosis, and the therapeutic challenge involved.


Subject(s)
Scleroderma, Localized/complications , Cachexia/etiology , Child , Fatal Outcome , Female , Humans , Leg Ulcer/etiology , Sepsis/etiology
5.
Bull Cancer ; 96 Suppl 2: 67-79, 2009 Sep 01.
Article in French | MEDLINE | ID: mdl-19903599

ABSTRACT

A group of 19 health professionals implicated in supportive care wanted to suggest some reflexions for organization, setting and evaluation of the supportive care in institutions and health territories. The suggested organization must be applicable to any cancer patient and the place of the care whatever the age, the stage of the disease; in the future, must be applicable to any patient with serious chronic illness. This organization must allow to optimize the accompaniment and the care of the patients and their close relations by 1) precise and regular analysis of their needs; 2) the respect of the continuity of the health care; 3) the setting of collaborative practice and transversality in the care. It is not a new medical speciality but a coordination of competences for patients and their families.


Subject(s)
Neoplasms , Humans
7.
Arch Pediatr ; 12(4): 438-41, 2005 Apr.
Article in French | MEDLINE | ID: mdl-15808436

ABSTRACT

We report the case of a five-day-old newborn with cyanosis. After exclusion of pulmonary and cardiac illness, methaemoglobinemia was diagnosed. Cyanosis is the first symptom of methaemoglobinaemia. Numerous causes of methaemoglobinemia have been described, with congenital and acquired forms, which are the most frequent. We discuss here the clinical features, diagnosis, and treatment of acquired methaemoglobinaemia in newborns with special emphasis on forms secondary to metoclopramide toxicity.


Subject(s)
Methemoglobinemia/chemically induced , Metoclopramide/adverse effects , Humans , Infant, Newborn , Male , Methemoglobinemia/diagnosis
8.
Arch Pediatr ; 10(7): 622-5, 2003 Jul.
Article in French | MEDLINE | ID: mdl-12907071

ABSTRACT

UNLABELLED: Late onset of neonatal infection could have been transmitted in prenatal period, but it is usually secondary to a postnatal transmission. CASE REPORT: A premature neonate developed staphylococcal pneumonia at 18 days of life. Genomic typing of the strains of Staphylococcus aureus obtained from the patient and from his mother (found in the endocervix culture 48 h before delivery) was identical. These strains were different from those isolated in other neonates colonised by S. aureus in the unit during at that moment. CONCLUSION: The observed case of staphylococcal pneumonia may correspond to a nosocomial infection secondary to a pre- or postnatal transmission of the agent by the mother.


Subject(s)
Infant, Premature , Pneumonia, Staphylococcal/transmission , Adult , Cross Infection , DNA, Bacterial , Female , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Male , Pregnancy , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/pathogenicity
9.
Arch Pediatr ; 9(2): 125-9, 2002 Feb.
Article in French | MEDLINE | ID: mdl-11915492

ABSTRACT

MATERIAL AND METHODS: This retrospective study reports 15 cases of hemophagocytic syndrome in children treated in our department during a eight-year period. RESULTS: Underlying diseases were acute lymphoblastic leukemia (n = 8) acute myeloblastic leukemia (n = 6) and Burkitt lymphoma (n = 1). Hemophagocytic syndrome was suspected after chemotherapy, in case of an unusual prolonged febrile neutropenia (n = 14) or isolated thrombocytopenia (n = 1). That fever was associated with cutaneous, pulmonary, hematologic, digestive and cardiac signs. Biological disorders included hypoprotidemia, hyponatremia, increased liver enzymes and fibrinopenia. Thrombocytopenia was observed in all patients and was associated with neutropenia for 14 of them. Diagnosis of hemophagocytic syndrome was always confirmed by bone marrow aspiration (infiltration with activated macrophages). Infection was documented in eight children. The treatment of hemophagocytic syndrome relied on steroids and resolution of symptoms occurred within three days of therapy. No recurrence of hemophagocytic syndrome was observed with a median follow up of two years and a half. CONCLUSION: Such complication should be suspected in cases of prolonged febrile neutropenia and/or thrombocytopenia, and confirmed by bone marrow aspiration. Indeed, steroid therapy is effective and chemotherapy can be then pursued.


Subject(s)
Histiocytosis, Non-Langerhans-Cell , Neutropenia/complications , Thrombocytopenia/complications , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Age Factors , Burkitt Lymphoma/drug therapy , Child , Child, Preschool , Female , Histiocytosis, Non-Langerhans-Cell/diagnosis , Histiocytosis, Non-Langerhans-Cell/drug therapy , Histiocytosis, Non-Langerhans-Cell/etiology , Humans , Infant , Leukemia, Myeloid, Acute/drug therapy , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Retrospective Studies , Time Factors
10.
Arch Pediatr ; 8(7): 751-3, 2001 Jul.
Article in French | MEDLINE | ID: mdl-11484460

ABSTRACT

Palliative care has recently been developed in adults. However, children die as well and quite a few articles have been published on this special issue. The object of this article is to summarize the available literature in order to call for the development of clinical policies and minimum standards adapted to French pediatrics.


Subject(s)
Child Welfare , Palliative Care , Terminal Care , Adult , Child , France , Health Policy , Humans , Neoplasms , Parent-Child Relations
11.
Biol Neonate ; 80(1): 68-73, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11474153

ABSTRACT

Previous studies have shown a reduction of dopaminergic D(2) receptors (D(2)R) in the striatum after hypoxia-ischemia in newborn rats. We show here an early and transient reduction of mRNA D(2)R in nonatrophic brains following hypoxia-ischemia. The left carotid artery of P7 rats was ligated followed by hypoxia for 2 h. The rats were sacrificed after 24 h, 48 h and 14 days. D(2)R mRNA was studied by in situ hybridization, the cell number by conventional histology, and neuronal and astrocyte differentiation by immunohistochemistry. A 20% reduction of striatal mRNA D(2)R occurred 24 h after hypoxia-ischemia, whereas no reduction was observed after 48 h and 14 days. There were no differences in total cell number and in the expression of neuronal (MAP-1, MAP-2) and astrocyte (GFAP) markers between both brain hemispheres nor between control and hypoxia-ischemia animals. The early decrease in mRNA D(2)R could explain the delayed reduced D(2)R after neonatal hypoxia-ischemia.


Subject(s)
Animals, Newborn , Gene Expression , Hypoxia-Ischemia, Brain/metabolism , RNA, Messenger/analysis , Receptors, Dopamine D2/genetics , Animals , Astrocytes/chemistry , Astrocytes/pathology , Cell Count , Corpus Striatum/chemistry , Corpus Striatum/pathology , Glial Fibrillary Acidic Protein/analysis , Immunohistochemistry , In Situ Hybridization , Rats , Rats, Wistar
12.
Eur J Clin Microbiol Infect Dis ; 20(2): 77-82, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11305476

ABSTRACT

The safety and efficacy of amphotericin B lipid complex (ABLC) were evaluated in a retrospective study of 46 paediatric patients with invasive infections. The study included a large proportion of patients who were refractory to or intolerant of conventional antifungal therapy. The mean age of the children was 9.7 +/- 4.8 years. Primary underlying conditions included mainly haematopoietic stem cell transplantation, leukaemia and lung transplantation. The mean daily dose given was 4.11 mg/kg for a mean duration of 38.7 days. At the end of therapy, 38 of 46 (83%) patients responded successfully to treatment with ABLC, including 18 of 23 (78%) with aspergillosis and 17 of 19 (89%) with candidiasis. ABLC was well tolerated, with a low incidence of adverse events. The mean creatinine value was 74.5 microl/mol/l at baseline and 78.2 micromol/l at the end of therapy. These results support the use of ABLC in the treatment of invasive fungal infections in children, including patients who have previously failed, or are intolerant of, traditional antifungal regimens.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Immunocompromised Host , Mycoses/drug therapy , Phosphatidylcholines/therapeutic use , Phosphatidylglycerols/therapeutic use , Adolescent , Amphotericin B/adverse effects , Antifungal Agents/adverse effects , Aspergillosis/drug therapy , Candidiasis/drug therapy , Child , Child, Preschool , Creatinine/urine , Drug Combinations , Female , Hematopoietic Stem Cell Transplantation , Humans , Infant , Leukemia/immunology , Lung Transplantation/immunology , Male , Mycoses/immunology , Phosphatidylcholines/adverse effects , Phosphatidylglycerols/adverse effects , Retrospective Studies
13.
Arch Pediatr ; 7(1): 58-65, 2000 Jan.
Article in French | MEDLINE | ID: mdl-10668088

ABSTRACT

Improving the management of dying children has always been a common desire among staff who take care of children with incurable life-threatening diseases. Pediatric oncologists are beginning to structure their practice based upon the approach to palliative care given to adults. In the first part of this report, the authors focus on technical care: comfort control and symptoms. The second part is devoted to pain management, a major aspect of pediatric palliative care. In the third part, psychosocial issues are developed, taking into account the point of view of children, siblings, parents and staff.


Subject(s)
Medical Oncology , Palliative Care , Pediatrics , Adolescent , Child , Child, Preschool , Humans , Infant , Pain Management , Quality of Life , Social Support
14.
Acta Paediatr ; 88(9): 1004-8, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10519344

ABSTRACT

High-frequency oscillation (HFO) is a technique frequently used in neonatal resuscitation, but which has yet to be evaluated. The use of intrathoracic pressures may have an effect on the cerebral circulation of immature neonates. The aim of this study was to examine the variations in cerebral blood velocity and oxygenation during brief pulmonary inflations (sighs), by focusing on alveolar recruitment. In this prospective study performed in 13 intubated and ventilated neonates (alpha = 5%; 1-beta = 80%), mean blood velocity and Doppler Resistance Index were measured, and variations in chromophores concentrations were evaluated by near infrared spectroscopy. Brief inflations at 4 cm H2O above the mean regulated intra-thoracic pressure did not cause any variation in the parameters measured. An explanation for this discordance with animal studies may be the level of pressure chosen, which could be more appropriate for the pulmonary compliance of neonates.


Subject(s)
Cerebrovascular Circulation , High-Frequency Ventilation , Infant, Premature/physiology , Female , Hemodynamics , Humans , Infant, Newborn , Lung/physiology , Male , Prospective Studies , Spectroscopy, Near-Infrared
15.
Pediatr Pulmonol ; 28(1): 31-8, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10406048

ABSTRACT

We conducted a prospective study of respiratory function in children undergoing bone marrow transplantation (BMT) for onco-hematological disorders. Each child was evaluated before and 100 days after BMT. The investigations included clinical examination, chest X-ray, and pulmonary function tests (PFT) to determine: slow vital capacity (VC), functional residual capacity (FRC), total lung capacity (TLC), forced expiratory volume in 1 s (FEV1), carbon monoxide diffusing capacity (DLCO), ratio of residual volume (RV) to TLC, and FEV1/VC. The values obtained before and after BMT were compared to predicted values, and the post-BMT values were compared to the pre-BMT values (Student's t-test). From 1986 to 1995, 77 children underwent BMT, of whom 39 were available for testing. The pre-BMT VC (P = 0.0234) and DLCO (P < 0.0001) were lower and FRC higher (P < 0.0001) than predicted values. After BMT, the VC (P = 0.004), TLC (P = 0.044), and FEV1 (P = 0.012) were lower, and the RV/TLC ratio was higher (P = 0.043), compared with pre-BMT data. The observed respiratory abnormalities were not clinically relevant. The only identifiable risk factor for a decrease in lung function was age at BMT. This study shows that some lung dysfunction may be present before BMT and be further altered by BMT. This stresses the need for longitudinal respiratory monitoring and follow up to detect such dysfunctions and to insure an optimal treatment program for these children.


Subject(s)
Bone Marrow Transplantation/methods , Hematologic Neoplasms/therapy , Respiration , Transplantation Conditioning/methods , Age Factors , Analysis of Variance , Bone Marrow Transplantation/mortality , Child , Child, Preschool , Female , Hematologic Neoplasms/diagnosis , Hematologic Neoplasms/mortality , Humans , Infant , Lung/diagnostic imaging , Lung/physiopathology , Male , Postoperative Period , Predictive Value of Tests , Preoperative Care , Prospective Studies , Radiography , Regression Analysis , Respiratory Function Tests , Risk Assessment , Survival Rate , Treatment Outcome
16.
Arch Pediatr ; 5(1): 41-4, 1998 Jan.
Article in French | MEDLINE | ID: mdl-10223111

ABSTRACT

UNLABELLED: The association of autoimmune hemolytic anemia and mature teratoma of the ovary is rare, particularly in childhood, but must be known and looked for since the treatment of teratoma allows to cure anemia as well. CASE REPORT: A 9 year-old girl was admitted for hemolytic anemia. The etiologic work-up revealed an autoimmune mechanism (IgG autoantibodies with complement), as well as an ovarian tumor after ultrasound sonography of the abdomen and pelvis. Surgical excision of the tumor was complete and uncomplicated. Pathological examination concluded to a mature teratoma. Anemia, as well as the signs of autoimmunity, disappeared a few weeks later and the child is doing well with several months of follow-up. CONCLUSION: This second reported pediatric case shows that an ovarian teratoma should be searched for with ultrasound sonography in any girl presenting with autoimmune hemolytic anemia, since surgical excision is sufficient to cure both anemia and the tumor.


Subject(s)
Anemia, Hemolytic, Autoimmune/complications , Ovarian Neoplasms/complications , Teratoma/complications , Anemia, Hemolytic, Autoimmune/blood , Autoantibodies/blood , Child , Complement System Proteins/analysis , Female , Humans , Immunoglobulin G/blood , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Teratoma/diagnostic imaging , Teratoma/pathology , Teratoma/surgery , Ultrasonography
18.
Pediatr Cardiol ; 18(1): 52-6, 1997.
Article in English | MEDLINE | ID: mdl-8960495

ABSTRACT

We report three cases of transient myocardial hypertrophy, diagnosed by echocardiography, occurring between the second and seventh days of life in neonates with initially normal ventricular myocardial wall thickness. The three term neonates had perinatal injury with acute fetal distress. In all three cases electrocardiographic and biologic signs of myocardial ischemia were present. The first echocardiographic results showed abnormalities in systolic or diastolic left ventricular function, without hypertrophy of the walls. The hypertrophic cardiomyopathy (HCM) occurred between days 2 and 7 and affected first the interventricular septum and the free wall of the right ventricle. The left ventricular posterior wall subsequently became abnormal, resulting in severe overall myocardial hypertrophy, which finally disappeared in all three cases between 1 and 5 months of life. Such observations of early severe and transient HCM have not been previously reported. We believe it is a consequence of myocardial ischemia due to acute fetal distress. The prognosis of this type of HCM is good, in contrast to that of other primitive HCM occurring in neonates.


Subject(s)
Cardiomyopathy, Hypertrophic/etiology , Fetal Distress/complications , Acute Disease , Cardiomyopathy, Hypertrophic/diagnostic imaging , Echocardiography, Doppler , Female , Humans , Infant, Newborn , Male , Myocardial Ischemia/complications , Prognosis
20.
Arch Pediatr ; 3(10): 977-83, 1996 Oct.
Article in French | MEDLINE | ID: mdl-8952791

ABSTRACT

BACKGROUND: The prognostic value of clinical and histological detection of testicular leukemia after completion of therapy is still debated. Immunohistochemical study could improve the results of this detection. PATIENTS AND METHODS: Between 1982 and 1992, 70 consecutive boys with acute lymphoblastic leukemia (ALL) and treated with the same therapeutic regimen were included in the study. Testicular biopsy (TB) was surgical and bilateral. One piece of tissue was fixed and analysed by conventional microscopy. An immunohistochemical study was performed on the other sample with a panel of anti-T and anti-B Mc Ab, including JCB 117 (anti-CD79a) which stains early pre B lymphoblasts. RESULTS: Twenty-five children relapsed while on treatment and did not undergo TB. Among the 45 boys who underwent routine TB, one had a diffuse infiltration seen in conventional histology. Thirty-nine had normal morphological and immunohistochemical study: among them, six relapsed subsequently in bone marrow; in this group, event free survival (EFS) was 85 +/- 10% with a median follow-up of 80 months after the biopsy. In the five remaining boys, anti-CD79a was found positive on blasts in four cases and anti-CD3 in one case; four of those relapsed, including two in the testes during the year following the biopsy; EFS was 20 +/- 36% (P = 0.001). CONCLUSIONS: New Mc Ab such as JCB 117 (anti-CD79a) might detect a minimal residual disease in the testes of children treated for ALL, particularly on routine histological material. These results, if confirmed in larger series, might influence further therapeutic strategy.


Subject(s)
Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Testis/pathology , Adolescent , Antibodies, Monoclonal , Antigens, CD/immunology , Biopsy , CD3 Complex/immunology , CD79 Antigens , Child , Child, Preschool , Humans , Immunohistochemistry , Male , Receptors, Antigen, B-Cell/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...